BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32882010)

  • 1. Persisting Muscle Dysfunction in Cushing's Syndrome Despite Biochemical Remission.
    Vogel F; Braun LT; Rubinstein G; Zopp S; Künzel H; Strasding F; Albani A; Riester A; Schmidmaier R; Bidlingmaier M; Quinkler M; Deutschbein T; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4490-8. PubMed ID: 32882010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of myopathy in Cushing's syndrome: evaluation of the German Cushing's Registry.
    Berr CM; Stieg MR; Deutschbein T; Quinkler M; Schmidmaier R; Osswald A; Reisch N; Ritzel K; Dimopoulou C; Fazel J; Hahner S; Stalla GK; Beuschlein F; Reincke M
    Eur J Endocrinol; 2017 Jun; 176(6):737-746. PubMed ID: 28325824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with low IGF-I after curative surgery for Cushing's syndrome have an adverse long-term outcome of hypercortisolism-induced myopathy.
    Vogel F; Braun L; Rubinstein G; Zopp S; Benedix S; Schneider H; Ritzel K; Schilbach K; Schmidmaier R; Beuschlein F; Bidlingmaier M; Reincke M
    Eur J Endocrinol; 2021 May; 184(6):813-821. PubMed ID: 33830940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid Receptor Polymorphisms Influence Muscle Strength in Cushing's Syndrome.
    Müller LM; Kienitz T; Deutschbein T; Riester A; Hahner S; Burger-Stritt S; Berr CM; Oßwald A; Braun L; Rubinstein G; Reincke M; Quinkler M
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31613324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cushing's syndrome: a model for sarcopenic obesity.
    Drey M; Berr CM; Reincke M; Fazel J; Seissler J; Schopohl J; Bidlingmaier M; Zopp S; Reisch N; Beuschlein F; Osswald A; Schmidmaier R
    Endocrine; 2017 Sep; 57(3):481-485. PubMed ID: 28702888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
    Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome.
    Vogel F; Braun L; Zopp S; Nowak E; Schreiner J; Benz I; Rubinstein G; Künzel H; Ritzel K; Kroiss M; Honegger J; Beuschlein F; Schilbach K; Teupser D; Bidlingmaier M; Reincke M
    Eur J Endocrinol; 2023 Apr; 188(4):375-384. PubMed ID: 36971260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thigh Muscle Fat Infiltration Is Associated With Impaired Physical Performance Despite Remission in Cushing's Syndrome.
    Martel-Duguech L; Alonso-Jiménez A; Bascuñana H; Díaz-Manera J; Llauger J; Nuñez-Peralta C; Biagetti B; Montesinos P; Webb SM; Valassi E
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 31912154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of sarcopenia after remission of hypercortisolism and its impact on HRQoL.
    Martel-Duguech L; Alonso-Jimenez A; Bascuñana H; Díaz-Manera J; Llauger J; Nuñez-Peralta C; Montesinos P; Webb SM; Valassi E
    Clin Endocrinol (Oxf); 2021 Nov; 95(5):735-743. PubMed ID: 34323296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study.
    Zhang CD; Li D; Singh S; Suresh M; Thangamuthu K; Nathani R; Achenbach SJ; Atkinson EJ; Van Gompel JJ; Young WF; Bancos I
    Eur J Endocrinol; 2023 Jul; 188(7):592-602. PubMed ID: 37395115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Cushing's syndrome on the gonadotrope axis and testicular functions in men.
    Papadakis GE; de Kalbermatten B; Dormoy A; Salenave S; Trabado S; Vieira-Pinto O; Richa C; Kamenicky P; Chanson P; Maione L; Pitteloud N; Young J
    Hum Reprod; 2023 Dec; 38(12):2350-2361. PubMed ID: 37742130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study.
    Ehrlich K; Morbach C; Reiter T; Heuschmann PU; Hannemann A; Fassnacht M; Störk S; Hahner S; Deutschbein T
    BMC Endocr Disord; 2021 Jan; 21(1):11. PubMed ID: 33419423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.
    Schernthaner-Reiter MH; Siess C; Gessl A; Scheuba C; Wolfsberger S; Riss P; Knosp E; Luger A; Vila G
    Endocrine; 2019 Apr; 64(1):157-168. PubMed ID: 30467627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of muscle function and health-related quality of life in patients with endogenous hypercortisolism: a cross-sectional study.
    Li D; Zhang CD; Saini J; Singh S; Nathani R; Thangamuthu K; Suresh M; Atkinson EJ; Achenbach SJ; Van Gompel J; Young WF; Bancos I
    Eur J Endocrinol; 2023 Jul; 188(7):603-612. PubMed ID: 37327378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptor polymorphism BclI with increased glucocorticoid sensitivity has a positive influence on quality of life in endogenous Cushing's syndrome in remission.
    Feldkamp L; Müller L; Deutschbein T; Detomas M; Hahner S; Strasburger CJ; Künzel H; Oßwald A; Braun L; Rubinstein G; Reincke M; Quinkler M; Kienitz T
    Eur J Endocrinol; 2023 Apr; 188(4):366-374. PubMed ID: 36995896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
    Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of procoagulant imbalance in Cushing's syndrome after short- and long-term remission of disease.
    Ferrante E; Serban AL; Clerici M; Indirli R; Scalambrino E; Carosi G; Padovan L; Locatelli M; Arosio M; Peyvandi F; Mantovani G; Tripodi A
    J Endocrinol Invest; 2022 Jan; 45(1):9-16. PubMed ID: 34115342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature.
    da Mota F; Murray C; Ezzat S
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1670-4. PubMed ID: 21816785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.